Get the Stockscreener App
155.11
0.43%
-0.62
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $155.11, with a volume of 894.29K.
It is down -0.43% in the last 24 hours and down -2.70% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$155.73
Open:
$155.27
24h Volume:
894.29K
Relative Volume:
0.37
Market Cap:
$44.11B
Revenue:
$21.92B
Net Income/Loss:
$1.76B
P/E Ratio:
25.34
EPS:
6.1223
Net Cash Flow:
$2.63B
1W Performance:
-1.29%
1M Performance:
-2.70%
6M Performance:
-16.98%
1Y Performance:
-23.25%
1-Day Range:
$154.55
$156.00
1-Week Range:
$152.78
$157.18
52-Week Range:
$152.78
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
155.06 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ISRG
Intuitive Surgical Inc
|
467.93 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
ALC
Alcon Inc
|
80.66 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.81 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.65 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $175 - 富途牛牛
Becton Dickinson And Co: A $5.3 Billion Quarter Signals Limited Growth Momentum - Smartkarma
Goldman Sachs Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $167 - 富途牛牛
Market Crash: The Healthcare Stocks I'd Buy Without Hesitation - The Motley Fool
Becton, Dickinson and Company (BD) 8-K Filing April 2026 – Company Details, Registered Securities, and Contact Information - Minichart
Becton, Dickinson and Company (BDX) Announces Executive Retireme - GuruFocus
Rick Byrd to Retire from BD - Finviz
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Richard E. Byrd to Retire as President of Interventional at Becton Dickinson - TradingView — Track All Markets
After 25 years at BD, a top medical device executive will retire - Stock Titan
Becton, Dickinson and Company (BDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD PureWick Urine Collection System - Finviz
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $202 - 富途牛牛
Becton Dickinson & Co. stock rises Wednesday, still underperforms market - MarketWatch
Deals tracker: Orlando Health to acquire Alabama health system - Modern Healthcare
Becton Dickinson (BDX) Pursues CE Mark for Liverty TIPS Stent Gr - GuruFocus
BD Delivers Next-Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - Finviz
BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - PR Newswire UK
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $198 - 富途牛牛
Becton Dickinson and Company Launches HemoSphere Stream Module - marketscreener.com
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $221 - 富途牛牛
Becton, Dickinson and Company (BDX) stock price, news, quote and history - Yahoo Finance UK
When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight - Finviz
BD Launches HemoSphere Stream Module for Continuous Blood Pressure Monitoring - Intellectia AI
BD Launches HemoSphere Stream™ Module for Continuous Non-Invasive Blood Pressure Monitoring - Intellectia AI
Rep. Kevin Hern Sells Becton, Dickinson and Company (NYSE:BDX) Shares - MarketBeat
BDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Becton, Dickinson and Company (NYSE:BDX) Given Average Rating of "Hold" by Analysts - MarketBeat
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
HF Advisory Group LLC Has $6.64 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Position Reduced by Trust Co. of Vermont - MarketBeat
BD Launches AI-Enabled Medication Dispensing System to the European Market - Finviz
European hospitals get BD AI medication cabinets in 15 languages - Stock Titan
List of 36 Acquisitions by Becton Dickinson (Apr 2026) - Tracxn
Becton Dickinson & Co. stock rises Tuesday, still underperforms market - MarketWatch
Fairleigh Dickinson University Appoints Cybersecurity Leader Miguel A. Crespo to Board of Trustees - Fairleigh Dickinson University
Pacific Capital Partners Ltd Buys 8,250 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Short Interest Down 16.8% in March - marketbeat.com
Accurate Wealth Management LLC Trims Position in Becton, Dickinson and Company $BDX - MarketBeat
Generate Investment Management Ltd Buys Shares of 65,000 Becton, Dickinson and Company $BDX - MarketBeat
Exchange Traded Concepts LLC Purchases 46,773 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Avity Investment Management Inc. Acquires 11,186 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Feld, Becton Dickinson & Co EVP, sells $11k in stock - Investing.com Australia
BD reports lower CEO pay but increases for other execs and the median worker - Medical Design & Outsourcing
-1.82% for Becton Dickinson stock as price nears 52-week low on persistent selling - Traders Union
How Becton Dickinson’s Medtech Pivot And Surgiphor FDA Clearance At BDX Has Changed Its Investment Story - simplywall.st
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):